Phase I and pharmacodynamic study of 17-(allylamino)-17- demethoxygeldanamycin in adult patients with refractory advanced cancers

Ramesh K. Ramanathan, Merrill J. Egorin, Julie L. Eiseman, Suresh Ramalingam, David Friedland, Sanjiv S. Agarwala, S. Percy Ivy, Douglas M. Potter, Gurkamal Chatta, Eleanor G. Zuhowski, Ronald G. Stoller, Cynthia Naret, Jianxia Guo, Chandra P. Belani

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint Dive into the research topics of 'Phase I and pharmacodynamic study of 17-(allylamino)-17- demethoxygeldanamycin in adult patients with refractory advanced cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences